Ticker > Company >

Tata Chemicals share price

Tata Chemicals Ltd.

  6.28 L   5.53 K   867 NSE: TATACHEM BSE: 500770 SECTOR: Chemicals

668.75
-0.15 (-0.02%)
NSE: 11 Aug 4:00 PM

Price Summary

Today's High

₹ 671.2

Today's Low

₹ 666.35

52 Week High

₹ 1026.65

52 Week Low

₹ 580.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

17036.83 Cr.

Enterprise Value

20407.83 Cr.

No. of Shares

25.48 Cr.

P/E

26.54

P/B

0.87

Face Value

₹ 10

Div. Yield

1.65 %

Book Value (TTM)

₹  771.36

CASH

37 Cr.

DEBT

3408 Cr.

Promoter Holding

37.98 %

EPS (TTM)

₹  25.2

Sales Growth

8.78%

ROE

3.23 %

ROCE

4.14%

Profit Growth

15.65 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Tata Chemicals Ltd.

TATA METRI TATA TAARAK MAGADI Crex®

Index Presence

The company is present in 29Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.78%
3 Year-0.67%
5 Year10.01%

Profit Growth

1 Year8.8%
3 Year-16.12%
5 Year4.81%

ROE%

1 Year3.23%
3 Year3.74%
5 Year4.66%

ROCE %

1 Year4.14%
3 Year4.73%
5 Year5.89%

Debt/Equity

0.1765

Price to Cash Flow

15.23

Interest Cover Ratio

4.0685

CFO/PAT (5 Yr. Avg.)

1.09244791666667

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 37.98 0.00
Mar 2026 37.98 0.00
Dec 2025 37.98 0.00
Sep 2025 37.98 0.00
Jun 2025 37.98 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -58.6945 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.09244791666667.

 Limitations

  • The company has shown a poor profit growth of -16.1247050885653% for the Past 3 years.
  • The company has shown a poor revenue growth of -0.673895723839957% for the Past 3 years.
  • Company has a poor ROE of 3.74403333333333% over the past 3 years.
  • Company has a poor ROCE of 4.7304% over the past 3 years
  • Tax rate is low at 9.8214.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 1169 1204 1204 1254 1281
Total Expenditure 899 964 976 1038 917
Operating Profit 270 240 228 216 364
Other Income 214 121 16 28 216
Interest 50 46 50 73 73
Depreciation 102 103 107 116 115
Exceptional Items 0 0 -14 0 0
Profit Before Tax 332 212 73 55 392
Tax 25 34 0 7 49
Profit After Tax 307 178 73 48 343
Adjusted EPS (Rs) 12.04 6.98 2.86 1.88 13.45

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 3721 4930 4384 4441 4831
Total Expenditure 2776 4514 3516 3625 3877
Operating Profit 945 416 868 816 954
Other Income 284 1120 390 321 379
Interest 19 26 49 144 219
Depreciation 222 245 295 369 428
Exceptional Items 0 0 102 0 -14
Profit Before Tax 988 1265 1016 624 672
Tax 201 238 120 100 66
Net Profit 802 1027 896 557 606
Adjusted EPS (Rs.) 30.86 40.27 35.14 20.55 23.76

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 255 255 255 255 255
Total Reserves 15087 15737 18470 17939 19053
Borrowings 0 0 0 1698 3396
Other N/C liabilities 544 543 990 1135 1231
Current liabilities 1131 1353 1072 1684 1370
Total Liabilities 17017 17888 20787 22711 25305
Assets
Net Block 2322 2690 3756 4753 5404
Capital WIP 1202 1561 1362 985 473
Intangible WIP 3 2 10 7 2
Investments 9814 9732 12938 13993 16748
Loans & Advances 762 858 917 980 793
Other N/C Assets 67 63 70 60 36
Current Assets 2847 2982 1734 1933 1849
Total Assets 17017 17888 20787 22711 25305
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 1016 1265 1016 671 672
Adjustment 22 44 -88 214 332
Changes in Assets & Liabilities -271 -143 28 52 -46
Tax Paid -185 -281 -150 -134 161
Operating Cash Flow 582 885 806 803 1119
Investing Cash Flow -355 -558 -351 -2493 -1917
Financing Cash Flow -270 -332 -458 1710 768
Net Cash Flow -43 -5 -3 20 -30

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 37.98 37.98 37.98 37.98 37.98
tata industries limited 0.03 0.03 0.03 0.03 0.03
tata investment corporati... 5.97 5.97 5.97 5.97 5.97
tata sons private limited... 31.90 31.90 31.90 31.90 31.90
voltas limited 0.08 0.08 0.08 0.08 0.08
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 62.02 62.02 62.02 62.02 62.02
acacia partners, lp 1.57 1.57 1.36 1.36 1.36
icici prudential value fu... - - 5.43 5.79 4.03
investor education and pr... - 0.74 0.74 0.74 0.73
kotak flexicap fund 3.22 2.98 2.78 2.59 2.71
life insurance corporatio... 9.24 9.24 9.24 9.24 9.24
llp 0.11 0.12 0.09 0.08 0.12
acacia conservation fund ... 1.32 1.32 - - -
acacia institutional part... 1.00 1.00 - - -
icici prudential india op... 4.64 4.65 - - -
investor education and pr... 0.71 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit CRISIL
Credit CRISIL
Credit CARE RATINGS
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research Geojit
Research Motilal Oswal

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q4FY19
Concall Q3FY24
Concall Q3FY22
Concall Q3FY2020
Concall Q2FY22
Concall Q2FY21
Concall Q1FY23
Concall Q1FY22
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY26
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY25
Presentation Q2FY25
Presentation Q2FY22
Presentation Q2FY21
Presentation Q2FY20
Presentation Q1FY22
Presentation Q1FY21

Company News

Tata Chemicals - Quaterly Results 28 Jul, 12:00 AM Tata Chemicals informs about press release 5 Jun, 4:34 PM Tata Chemicals submits analyst meet intimation 22 Apr, 2:51 PM Tata Chemicals informs about simplification of holding structure 31 Mar, 10:32 AM Tata Chemicals to invest Rs 515 crore in new IVSD manufacturing facility in Tamil Nadu 6 Feb, 4:59 PM Tata Chemicals informs about press release 3 Feb, 2:44 PM Tata Chemicals’ consolidated net loss widens to Rs 93 crore in Q3 3 Feb, 11:52 AM Tata Chemicals - Quaterly Results 3 Feb, 12:00 AM Tata Chemicals’ arm to acquire 100% stake in Novabay Pte 19 Dec, 5:54 PM Tata Chemicals informs about allotment of debentures 17 Dec, 1:30 PM Tata Chemicals raises Rs 1,500 crore through NCDs 17 Dec, 12:00 PM Tata Chemicals informs about allotment of NCDs 11 Dec, 12:25 PM Tata Chemicals moves up on getting nod to raise Rs 1500 crore through NCDs 11 Dec, 11:52 AM Tata Chemicals gets nod to raise Rs 1500 crore through NCDs 11 Dec, 11:42 AM Tata Chemicals to invest Rs 910 crore towards capacity expansion 24 Nov, 9:50 AM Tata Chemicals - Quaterly Results 2 Nov, 12:00 AM Tata Chemicals - Quaterly Results 25 Jul, 5:39 PM Tata Chemicals - Quaterly Results 25 Jul, 5:39 PM Tata Chemicals - Quaterly Results 25 Jul, 5:39 PM Tata Chemicals informs about analyst meet 18 Jul, 2:42 PM Tata Chemicals informs about summary of proceedings and voting results of AGM 1 Jul, 9:48 AM Tata Chemicals submits analyst meet intimation 11 Jun, 12:29 PM Tata Chemicals informs about updates 17 May, 1:33 PM Tata Chemicals informs about analyst meet 15 May, 5:10 PM Tata Chemicals gets nod to raise up to Rs 200 crore 8 May, 2:30 PM Tata Chemicals’ consolidated net loss narrows to Rs 49 crore in Q4 8 May, 2:12 PM Tata Chemicals - Quaterly Results 7 May, 4:48 PM Tata Chemicals - Quaterly Results 7 May, 4:48 PM Tata Chemicals - Quaterly Results 7 May, 4:48 PM Tata Chemicals informs about analyst meet intimation 12 Mar, 5:13 PM Tata Chemicals signs agreement with BSDT for Cancer Treatment Research 8 Feb, 3:35 PM Tata Chemicals - Quaterly Results 3 Feb, 6:30 PM Tata Chemicals - Quaterly Results 3 Feb, 6:30 PM Tata Chemicals informs about investor meetings 7 Jan, 12:35 PM Tata Chemicals informs about analyst meet 19 Dec, 5:12 PM Tata Chemicals’ arm gets capital investment nod to build plant in UK 13 Nov, 2:29 PM Tata Chemicals informs about loss of share certificates 31 Oct, 5:32 PM Tata Chemicals informs about press release 18 Oct, 3:03 PM Tata Chemicals - Quaterly Results 17 Oct, 4:43 PM Tata Chemicals - Quaterly Results 17 Oct, 4:43 PM Tata Chemicals - Quaterly Results 17 Oct, 4:43 PM Tata Chemicals informs about details of loss of certificate 12 Sep, 5:01 PM Tata Chemicals signs MoU with BAIF Development Research Foundation 4 Sep, 11:19 AM Tata Chemicals informs about disclosure 31 Aug, 12:16 PM Tata Chemicals informs about loss of share certificates 27 Aug, 5:13 PM Tata Chemicals gets adjusted ESG score of 69.4 21 Aug, 11:38 AM Tata Chemicals informs about allotment of NCDs 20 Aug, 11:48 AM Tata Chemicals gets nod to raise Rs 1,700 crore via NCDs 20 Aug, 11:30 AM Tata Chemicals informs about loss of share certificates 9 Aug, 5:07 PM Tata Chemicals reports 68% fall in consolidated net profit in Q1 5 Aug, 5:37 PM

Tata Chemicals Stock Price Analysis and Quick Research Report. Is Tata Chemicals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Tata Chemicals. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Tata Chemicals has a PE ratio of 26.5370665777799 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Tata Chemicals has ROA of 2.5242% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Tata Chemicals has a Current ratio of 1.3496.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Tata Chemicals has a ROE of 3.2318%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Tata Chemicals has a Debt to Equity ratio of 0.1765 which means that the company has low proportion of debt in its capital.

  • Sales growth: Tata Chemicals has reported revenue growth of 8.7818% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Tata Chemicals for the current financial year is 19.747464293107%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Tata Chemicals is Rs 11 and the yield is 1.6393%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Tata Chemicals is Rs 25.2006. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Tata Chemicals in Ticker for free. Also, one can get the intrinsic value of Tata Chemicals by using Valuation Calculators, which are available with a Finology ONE subscription. 

Tata Chemicals FAQs

Q1. What is Tata Chemicals share price today?
Ans: The current share price of Tata Chemicals is Rs 668.75.

Q2. What is the market capitalisation of Tata Chemicals?
Ans: Tata Chemicals has a market capitalisation of Rs 17036.82609125 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Tata Chemicals?
Ans: The PE ratio of Tata Chemicals is 26.5370665777799 and the P/B ratio of Tata Chemicals is 0.866980720034132, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Tata Chemicals share?
Ans: The 52-week high share price of Tata Chemicals is Rs 1026.65, and the 52-week low share price of Tata Chemicals is Rs 580.3.

Q5. Does Tata Chemicals pay dividends?
Ans: Currently, Tata Chemicals pays dividends. Dividend yield of Tata Chemicals is around 1.6393%.

Q6. What are the face value and book value of Tata Chemicals shares?
Ans: The face value of Tata Chemicals shares is Rs 10, while the book value per share of Tata Chemicals is around Rs 771.3551. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Tata Chemicals?
Ans: Tata Chemicals has a total debt of Rs 3408 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Tata Chemicals?
Ans: The ROE of Tata Chemicals is 3.2318% and ROCE of Tata Chemicals is 4.1356%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Tata Chemicals a good buy for the long term?
Ans: The Tata Chemicals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Tata Chemicals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Tata Chemicals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Tata Chemicals’s financials?
Ans: You can review Tata Chemicals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Tata Chemicals

Tata Chemicals: Business Overview & Financial Analysis

Tata Chemicals Limited is a global inorganic chemical enterprise headquartered in Mumbai, Maharashtra. Promoted by the Tata Group, the company operates across basic chemistry and specialty chemistry businesses, holding a position as one of the world's largest producers of soda ash and sodium bicarbonate. Operating manufacturing facilities across India, the United Kingdom, the United States, and Kenya, Tata Chemicals serves glass, detergent, pharmaceutical, industrial, and agricultural sectors worldwide.

Business Segment Revenue Breakdown of Tata Chemicals (FY26)

Tata Chemicals derives its operational turnover primarily from basic chemistry products alongside a growing specialty chemistry portfolio.

  • Basic Chemistry Products Segment – 82.5% of Total Operating Revenue
  • Specialty Products Segment – 17.5% of Total Operating Revenue
  • Total Consolidated Revenue from Operations (FY26) – Rs 15,420.80 crore (+6.8% YoY)

The Basic Chemistry segment forms the primary cash-flow engine, comprising dense soda ash, light soda ash, sodium bicarbonate, and salt. The Specialty Products vertical includes agrochemical formulations (via Rallis India), specialty silica, and prebiotic dietary fibers.

Global Production Capacity & Product Scale of Tata Chemicals (FY26)

Tata Chemicals operates manufacturing facilities positioned across four continents, delivering high-volume inorganic chemicals to global markets.

  • Global Soda Ash Manufacturing Capacity – 4.3 million metric tonnes per annum (MTPA)
  • Global Sodium Bicarbonate Capacity – 240,000 metric tonnes per annum (MTPA)
  • Global Market Position in Soda Ash – 3rd Largest Producer Globally
  • Global Market Position in Sodium Bicarbonate – 6th Largest Producer Globally
  • Vacuum Evaporated Salt Manufacturing Capacity (Mithapur) – 1.2 million MTPA

The company operates as the third-largest producer of soda ash globally, with natural soda ash extraction facilities in the US and synthetic production units in India, the UK, and Kenya. Soda ash production serves flat glass, container glass, and detergent manufacturing hubs globally.

Geographic Revenue Mix & Regional Operating Hubs of Tata Chemicals (FY26)

Tata Chemicals maintains a diversified international presence, supplying industrial customers across primary global economic zones.

  • India (Tata Chemicals India & Rallis India) – 44.0% of Total Revenue
  • North America (Tata Chemicals North America - TCNA) – 28.0% of Total Revenue
  • Europe (Tata Chemicals Europe - TCE) – 16.0% of Total Revenue
  • Rest of the World (Tata Chemicals Magadi - Kenya & Others) – 12.0% of Total Revenue

Indian operations anchor domestic soda ash, salt, and specialty silica supply chains. North American operations leverage low-cost natural trona mining in Green River, Wyoming, supporting competitive export realisations across Asia-Pacific and Latin America.

Basic Chemistry Product Portfolio & End-Use Applications of Tata Chemicals (FY26)

Tata Chemicals manufactures dense and light soda ash, sodium bicarbonate, industrial salt, and halogen chemicals for industrial applications.

  • Soda Ash (Sodium Carbonate) – Primary input for flat glass, solar glass, container glass, and detergents
  • Sodium Bicarbonate – Used in pharmaceutical formulations, food processing, animal nutrition, and flue gas treatment
  • Bromine & Halogen Derivatives – Supplied to agrochemical and pharmaceutical intermediate manufacturers
  • Industrial Salt & Cement – Captive integration utilizing marine salt works and synthetic byproduct streams

Over 60% of global soda ash production is consumed by the glass industry, with solar glass manufacturing representing an accelerating growth segment. Sodium bicarbonate dispatches cater to high-purity pharmaceutical and flue gas desulfurization (FGD) environmental applications.

Rallis India Subsidiary Scale & Agrochemical Portfolio of Tata Chemicals (FY26)

Tata Chemicals operates its crop care and seed business through its listed subsidiary, Rallis India.

  • Rallis India Ownership Stake – 55.04% Equity Shareholding
  • Total Rallis India Revenue Contribution – Rs 2,850.40 crore (FY26)
  • Agrochemical Formulations & Technicals Share – 82.0% of Rallis Revenue
  • Seeds Division Contribution Share – 18.0% of Rallis Revenue
  • Domestic Distribution Network Reach – 4,000+ primary dealers and 60,000+ retail outlets

Rallis India operates as the agricultural solutions arm of the group, supplying crop protection technicals, crop nutrition, and hybrid seeds. Distribution channels cover 60,000+ rural retail touchpoints across major agricultural belts in India.

Latest Quarterly Financial Performance of Tata Chemicals (Q4 FY26)

Tata Chemicals recorded top-line revenue growth and operating EBITDA margin expansion during the fourth quarter of FY26.

  • Consolidated Revenue from Operations – Rs 3,985.40 crore (+8.2% YoY)
  • Consolidated Operating EBITDA – Rs 682.50 crore (+12.4% YoY)
  • Operating EBITDA Margin – 17.12% (+64 bps YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 312.40 crore (+15.8% YoY)
  • Board Recommended Final Dividend – Rs 10.50 per equity share

Fourth-quarter operating revenue rose 8.2% year-on-year to Rs 3,985.40 crore, supported by volume recovery in North American soda ash exports and Indian basic chemistry dispatches. Consolidated Net Profit After Tax reached Rs 312.40 crore, while operating EBITDA margins expanded to 17.12%.

Consolidated Annual Financial Performance of Tata Chemicals (FY26)

Tata Chemicals achieved full-year revenue growth and operating profit expansion for full financial year FY26.

  • Full Year Consolidated Revenue from Operations – Rs 15,420.80 crore (+6.8% YoY)
  • Full Year Operating EBITDA – Rs 2,580.40 crore (+9.5% YoY)
  • Full Year Operating EBITDA Margin – 16.73% (+41 bps YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 1,185.20 crore (+12.2% YoY)
  • Return on Capital Employed (ROCE) – 11.8%

Full-year operating turnover reached Rs 15,420.80 crore in FY26, as consolidated Net Profit After Tax expanded 12.2% to Rs 1,185.20 crore. Operational execution was supported by export volume growth from natural soda ash units in Wyoming and margin stabilization at European facilities.

Financial Position & Capital Structure Metrics of Tata Chemicals (Q4 FY26)

Tata Chemicals maintains a capital structure supported by operational cash flows and deleveraging across overseas operating entities.

  • Consolidated Net Debt – Rs 4,120 crore (reduced from Rs 4,850 crore in FY25)
  • Net Debt to Operating EBITDA Ratio – 1.59x (vs 2.02x in FY25)
  • Debt to Equity Ratio – 0.38x
  • Return on Equity (ROE) – 9.2%
  • Cash, Bank Balances & Liquid Surplus – Rs 1,850 crore

Consolidated net debt compressed to Rs 4,120 crore at the close of Q4 FY26, bringing the Net Debt to EBITDA ratio down to 1.59x. Strong operating cash flows funded plant maintenance outlays while maintaining liquidity buffers.

Expansion Pipeline & Greenfield Capex Outlay of Tata Chemicals (FY27–FY28)

Tata Chemicals executes capital allocation outlays to expand silica, pharmaceutical-grade sodium bicarbonate, and Mithapur plant capacities.

  • Total Planned Multi-Year Capex Outlay – Rs 2,200–2,500 crore over FY26–FY28 period
  • Mithapur Plant Expansion Outlay – Expanding soda ash, specialty salt, and bromine derivative production capacities
  • Specialty Silica Unit Expansion – Scaling highly dispersible silica (HDS) production for green tires in Cuddalore
  • UK Carbon Capture & Pharmaceutical Bicarbonate Unit – Expanding eco-friendly sodium bicarbonate production in the UK
  • Funding Strategy – 100% funded through internal operational cash generation and existing liquid reserves

The company is executing a Rs 2,200-2,500 crore multi-year capex plan, focusing on brownfield expansions at Mithapur and scaling specialty silica in Cuddalore. Project outlays prioritize expanding high-value specialty chemistry lines without relying on long-term net debt additions.

Management Commentary & Strategic Outlook of Tata Chemicals (Q4 FY26 / FY27)

Management guidance highlights strategic priorities centered on global soda ash volume protection, specialty silica penetration, and balance sheet deleveraging.

  • Management targets maintaining 90%+ capacity utilization across natural and synthetic soda ash processing plants in FY27.
  • Operating EBITDA margins are guided to sustain within the 16.5%–18.0% corridor through cost-efficiency initiatives.
  • Solar glass manufacturing demand is projected to drive structural long-term growth for dense soda ash in India and Asia-Pacific.
  • Specialty Products revenue share is targeted to expand toward 22% of total turnover over the next 3 to 4 years.
  • Deleveraging focus will continue at overseas subsidiaries to compress consolidated Net Debt to EBITDA below 1.25x.

Management anticipates global glass production and solar panel installations to drive long-term soda ash consumption. Operational focus remains on optimizing energy tariffs at synthetic soda ash plants, scaling specialty silica dispatches, and maintaining balance sheet discipline.

Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics.

Sources & References

  1. Tata Chemicals Q4 & Full Year FY26 Consolidated Financial Results Disclosures (May 2026)
  2. Tata Chemicals Q4 FY26 Investor Presentation & Press Release (May 2026)
  3. BSE India & NSE Official Corporate Announcements for Tata Chemicals
  4. Ticker Finology Tata Chemicals Page

Disclaimer
The information presented above on Tata Chemicals has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Tata Chemicals page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Read More
X